CRH

CRH
Name	Corticotropin-releasing hormone
Othernames	Corticotropin-releasing factor
Discovered	1981
Discovered by	Wylie Vale
Gene	CRH
Organism	Homo sapiens
Length	41 amino acids (human peptide)
Function	Stress hormone regulator
Location	Hypothalamus, placenta, peripheral tissues

CRH

Corticotropin-releasing hormone is a 41–amino-acid peptide produced primarily in the paraventricular nucleus of the hypothalamus that orchestrates neuroendocrine responses to stress. It acts as a principal regulator of the hypothalamic–pituitary–adrenal axis and integrates signals from limbic, brainstem, and peripheral sources to modulate secretion of adrenocorticotropic hormone. Discovered in 1981, the peptide has broad roles in homeostasis, development, and pathophysiology across human and vertebrate biology.

Introduction

CRH was purified and sequenced following work by researchers including Wylie Vale and colleagues, linking the peptide to regulation of pituitary function and stress reactivity. The gene encoding CRH is mapped within the human genome and is transcriptionally regulated by factors responsive to neural inputs and circulating signals. CRH family peptides and their receptors are conserved across vertebrates, connecting to comparative studies in rodents, primates, and teleost fish that illuminate evolutionary conservation of stress circuitry. Major hubs interacting with CRH include the hypothalamus, pituitary, adrenal cortex, amygdala, hippocampus, and brainstem nuclei.

Biology and Physiology

CRH neurons in the paraventricular nucleus project to the median eminence to control release of adrenocorticotropic hormone from corticotrophs in the anterior pituitary via CRH receptor type 1 activation. Peripheral sources such as the placenta produce CRH with roles in parturition and fetal development, while extra-hypothalamic expression in the amygdala and locus coeruleus coordinates autonomic and behavioral arousal. CRH signaling engages G protein–coupled receptors linked to cyclic AMP pathways and intracellular kinases, modulating gene transcription, peptide release, and synaptic plasticity. Interactions with monoaminergic nuclei, such as the dorsal raphe and ventral tegmental area, connect CRH function to serotonergic and dopaminergic systems, influencing affective states and motivated behavior. Feedback regulation involves glucocorticoids produced by the adrenal cortex acting on glucocorticoid receptors in hypothalamic and limbic sites to suppress CRH transcription.

Clinical Significance and Disorders

Alterations in CRH synthesis, release, or receptor function are implicated in psychiatric conditions including major depressive disorder, anxiety disorders, post-traumatic stress disorder, and bipolar disorder; studies cite dysregulated hypothalamic–pituitary–adrenal axis markers in cohorts from clinical centers and longitudinal studies. Perinatal overproduction of placental CRH associates with preterm birth and obstetric complications documented in obstetrics research. Endocrinopathies such as Cushing disease, secondary adrenal insufficiency, and congenital disorders affecting pituitary corticotrophs involve disrupted CRH responsiveness. Neurodegenerative conditions and chronic inflammatory diseases show dysregulated CRH-related signaling in neuropathology and systemic responses, with comorbidity patterns reported in epidemiological investigations.

Diagnostic and Measurement Methods

CRH function and HPA axis integrity are assessed using biochemical assays, stimulation and suppression tests, and imaging paradigms. Plasma and cerebrospinal fluid CRH concentrations are measured by immunoassays developed from monoclonal antibodies with cross-validation against mass spectrometry; dynamic tests include CRH stimulation tests, dexamethasone suppression tests, and combined dexamethasone–CRH protocols used in endocrine practice and research. Neuroimaging modalities such as functional magnetic resonance imaging and positron emission tomography map CRH-related activity indirectly through limbic and brainstem activation patterns in psychiatric cohorts. Genetic and transcriptomic profiling in cohorts from genome-wide association studies and expression atlases probe CRH gene regulation across tissues.

Therapeutic and Research Applications

CRH receptors, particularly CRHR1 and CRHR2, are targets for pharmacological modulation; small-molecule antagonists and peptide analogs have been developed and tested in clinical trials for depression, anxiety, irritable bowel syndrome, and inflammatory conditions. Translational research uses rodent models, nonhuman primate studies, and organoid systems to explore CRH’s role in development, stress resilience, and sex-specific responses, informing therapeutic strategies. In obstetrics, measurement of placental CRH informs risk stratification for preterm labor and guides interventions in perinatal medicine. Ongoing research integrates neuroendocrine, immunological, and genomic approaches to refine biomarker panels and to develop receptor-selective agents with improved efficacy and tolerability.

Wylie Vale Paraventricular nucleus Hypothalamic–pituitary–adrenal axis Adrenocorticotropic hormone Pituitary gland Adrenal cortex Amygdala Hippocampus Locus coeruleus Dorsal raphe nucleus Ventral tegmental area Serotonin Dopamine Glucocorticoid receptor Cushing disease Dexamethasone suppression test Placenta Preterm birth Major depressive disorder Anxiety disorder Post-traumatic stress disorder Bipolar disorder Irritable bowel syndrome Functional magnetic resonance imaging Positron emission tomography Mass spectrometry Genome-wide association study Monoclonal antibody Nonhuman primate Rodent model Organoid CRHR1 CRHR2 HPA axis dysfunction Endocrinology Perinatal medicine Neuroendocrinology Psychiatry Immunology Wiley (publisher) Oxford University Press Nature Science The Lancet New England Journal of Medicine Journal of Clinical Endocrinology & Metabolism Proceedings of the National Academy of Sciences Cell Neuron Molecular Psychiatry Biological Psychiatry Frontiers in Neuroscience British Journal of Psychiatry American Journal of Psychiatry European Journal of Endocrinology Journal of Neuroscience Endocrine Reviews Clinical Endocrinology and Metabolism American Journal of Obstetrics and Gynecology Society for Neuroscience Endocrine Society World Health Organization National Institutes of Health European Research Council

Category:Peptide hormones